Literature DB >> 1377947

The ontogeny and functional characteristics of human B-1 (CD5+ B) cells.

N M Bhat1, A B Kantor, M M Bieber, A M Stall, L A Herzenberg, N N Teng.   

Abstract

We demonstrate that, on average, greater than 90% of B lymphocytes in fetal spleen express CD5 at gestational ages of 17-23 weeks. Similarly, CD5+ B cells (B-1 cells) are the major B cell subset in umbilical cord blood. These findings depend on the optimization of fluorochrome conjugated anti-CD5 reagents for multiparameter fluorescent-activated cell sorter (FACS) analysis. From infancy through childhood the percentage of B-1 cells gradually diminishes in both spleen and peripheral blood. Stable adult levels, 25-35% of the total B cell population, are reached in late adolescence. The decrease in the percentage of B-1 cells in spleen is accompanied by an increase in conventional (CD5-) B cells, keeping the percentage of total B cells per mononuclear cells relatively constant. In contrast, in peripheral blood, the concentration of both B-1 cells and total B cells decreases, while T cells increase. At the functional level, we show that polyreactive IgM autoantibodies are produced by FACS-sorted CD5high B cells, but not by CD5- B cells from adolescent spleen. In contrast, fetal splenic CD5high and CD5- B cells appear functionally uniform, both producing IgM autoantibodies that are typical of B-1 cells. The apparent level of CD5- B cells in fetal spleen, on average 10% of total B cells, may still result from limitations of our reagent. The prominence of B-1 cells in fetal spleen and cord blood, the gradual reduction of B-1 cells with increasing age, and its characteristic repertoire, all suggest a role for this cell type in immunologically immature hosts.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1377947     DOI: 10.1093/intimm/4.2.243

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  29 in total

Review 1.  Somatic hypermutation in human B cell subsets.

Authors:  N S Longo; P E Lipsky
Journal:  Springer Semin Immunopathol       Date:  2001-12

Review 2.  B-1 B cell development in the fetus and adult.

Authors:  Encarnacion Montecino-Rodriguez; Kenneth Dorshkind
Journal:  Immunity       Date:  2012-01-27       Impact factor: 31.745

3.  Molecular single-cell analysis reveals that CD5-positive peripheral blood B cells in healthy humans are characterized by rearranged Vkappa genes lacking somatic mutation.

Authors:  M Fischer; U Klein; R Küppers
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

4.  Isolation and nucleotide sequence of sheep CD5.

Authors:  S A Fabb; K J Gogolin-Ewens; J F Maddox
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

5.  Ontogeny of leucocyte populations in the spleen of fetal lambs with emphasis on the early prominence of B cells.

Authors:  C M Press; W R Hein; T Landsverk
Journal:  Immunology       Date:  1993-12       Impact factor: 7.397

6.  Presence of activated B-1 cells in chronic inflamed gingival tissue.

Authors:  M Aramaki; T Nagasawa; T Koseki; I Ishikawa
Journal:  J Clin Immunol       Date:  1998-11       Impact factor: 8.317

7.  Lymphocyte subset differences in patients with chronic fatigue syndrome, multiple sclerosis and major depression.

Authors:  M J Robertson; R S Schacterle; G A Mackin; S N Wilson; K L Bloomingdale; J Ritz; A L Komaroff
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

8.  Developmental expression of B cell molecules in equine lymphoid tissues.

Authors:  J M B Prieto; R L Tallmadge; M J B Felippe
Journal:  Vet Immunol Immunopathol       Date:  2016-12-13       Impact factor: 2.046

9.  Children with chronic renal failure have reduced numbers of memory B cells.

Authors:  A H M Bouts; J C Davin; R T Krediet; L A H Monnens; J Nauta; C H Schröder; R A W van Lier; T A Out
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

Review 10.  Immunologic and Hematological Abnormalities in Necrotizing Enterocolitis.

Authors:  Akhil Maheshwari
Journal:  Clin Perinatol       Date:  2015-05-13       Impact factor: 3.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.